☰

cached image

Richard DiMarchi

Affiliations: 
Chemistry Indiana University, Bloomington, Bloomington, IN, United States 
Area:
endocrinology, specifically diabetes
Website:
http://dimarchi.chem.indiana.edu/
Google:
"Richard DiMarchi"
Bio:

http://www.indiana.edu/~rdmweb/

Mean distance: 8.5
 		SNBCP
Tree Publications Similar researchers PubMed Report error

Parents

Sign in to add mentor
Frank R.N. Gurd grad student 1974-1979 Indiana University
 (Semisynthetic studies of the amino-terminal region of sperm whale myoglobin and the complete amino acid sequence of the major component myoglobin of the finback whale (Balaenoptera physalus))
R. Bruce Merrifield post-doc 1979-1981 Rockefeller

Children

Sign in to add trainee
Arnab De research assistant 2004-2007 Indiana University
Beili Quan grad student 2010 Indiana University
Joseph R. Chabenne grad student 2011 Indiana University
Brian Finan grad student 2011 Indiana University
Zachary Kaur grad student 2011 Indiana University
James T. Patterson grad student 2006-2011 Indiana University
Shujiang Cheng grad student 2012 Indiana University
Brian P. Ward grad student 2012 Indiana University
Jonathan Michael Meyers grad student 2005-2012 Indiana University
Chenguang Ouyang grad student 2013 Indiana University
Alexander Zaykov post-doc 2012-2015 Indiana University

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Chrudinová M, Kirk NS, Chuard A, et al. (2024) A Viral Insulin-like Peptide Inhibits IGF-1 Receptor Phosphorylation and Regulates IGF1R Gene Expression. Molecular Metabolism. 101863
Liskiewicz A, Khalil A, Liskiewicz D, et al. (2023) Glucose-dependent insulinotropic polypeptide regulates body weight and food intake via GABAergic neurons in mice. Nature Metabolism
Sachs S, Götz A, Finan B, et al. (2023) GIP receptor agonism improves dyslipidemia and atherosclerosis independently of body weight loss in preclinical mouse model for cardio-metabolic disease. Cardiovascular Diabetology. 22: 217
Campbell JE, Müller TD, Finan B, et al. (2023) GIPR/GLP-1R dual agonist therapies for diabetes and weight loss-chemistry, physiology, and clinical applications. Cell Metabolism
Moreau F, Kirk NS, Zhang F, et al. (2022) Interaction of a viral insulin-like peptide with the IGF-1 receptor produces a natural antagonist. Nature Communications. 13: 6700
Quarta C, Stemmer K, Novikoff A, et al. (2022) GLP-1-mediated delivery of tesaglitazar improves obesity and glucose metabolism in male mice. Nature Metabolism. 4: 1071-1083
Kim T, Nason S, Antipenko J, et al. (2022) Hepatic TORC2 Signaling Facilitates Acute Glucagon-Receptor Enhancement of Insulin-Stimulated Glucose Homeostasis in Mice. Diabetes
Knerr PJ, Mowery SA, Douros JD, et al. (2022) Next generation GLP-1/GIP/glucagon triple agonists normalize body weight in obese mice. Molecular Metabolism. 101533
Dhayalan B, Glidden MD, Zaykov AN, et al. (2022) Peptide Model of the Mutant Proinsulin Syndrome. I. Design and Clinical Correlation. Frontiers in Endocrinology. 13: 821069
Tan Q, Akindehin SE, Orsso CE, et al. (2022) Recent Advances in Incretin-Based Pharmacotherapies for the Treatment of Obesity and Diabetes. Frontiers in Endocrinology. 13: 838410
See more...